Popular
The OD As a Salesperson + the Ocular Side of Oncology
Modern OptometryThe OD As a Salesperson + the Ocular Side of Oncology
Cecelia Koetting, OD, FAAO
Face Value with Modern Aesthetics: Review of Global Aesthetics Market Analysis (Part 2)
Modern AestheticsFace Value with Modern Aesthetics: Review of Global Aesthetics Market Analysis (Part 2)
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
CME/CEコンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
Barbara O'Brien, MD
Advanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
Practical DermatologyAdvanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
Preetha Muralidharan, MBBS, MPH
Rebeca Martinez, MD
Anisha B. Patel, MD
Going Beyond Staging for Gene Expression Profiling in Melanoma and Cutaneous Squamous Cell Carcinoma
Practical DermatologyGoing Beyond Staging for Gene Expression Profiling in Melanoma and Cutaneous Squamous Cell Carcinoma
Umer Nadir, MD
George Jeha, MD
Stan Tolkachjov, MD, FAAD, FACMS
Programs
TOGETHER-PsO: Dual Therapy for Psoriasis and Obesity
Practical DermatologyTOGETHER-PsO: Dual Therapy for Psoriasis and Obesity
Two Buyer Perspectives Across the Dermatology and Aesthetics Market
Practical DermatologyTwo Buyer Perspectives Across the Dermatology and Aesthetics Market
Clint Bundy
Drew Thomas
Going Beyond Staging for Gene Expression Profiling in Melanoma and Cutaneous Squamous Cell Carcinoma
Practical DermatologyGoing Beyond Staging for Gene Expression Profiling in Melanoma and Cutaneous Squamous Cell Carcinoma
Umer Nadir, MD
George Jeha, MD
Stan Tolkachjov, MD, FAAD, FACMS
Mobilization Outcomes After Aneurysmal Subarachnoid Hemorrhage
NeuroFrontiersMobilization Outcomes After Aneurysmal Subarachnoid Hemorrhage
Consensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
NeuroFrontiersConsensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
Clinical Practice
The Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
NeuroFrontiersThe Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
Jay Max Findlay
Spotting the Warning Signs of Subarachnoid Hemorrhage
NeuroFrontiersSpotting the Warning Signs of Subarachnoid Hemorrhage
Jay Max Findlay
Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
CME/CEGrooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
Pam R. Taub, MD, FACC, FASPC
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
MinuteCE®Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Jennifer Johnson, MD, PhD
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
MinuteCE®Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Adam J. Luginbuhl, MD
All About Allergies: Kids Ask the Expert
Clinician's RoundtableAll About Allergies: Kids Ask the Expert
Hany Ibrahim
Doctors Lounge
Inside Medical Affairs: MSL Insights on AI, Strategy, and Impact
MAPSChatsInside Medical Affairs: MSL Insights on AI, Strategy, and Impact
Matt Birnholz, MD
Brandon Young, PhD
Collaboration in Medical Affairs: Increasing Value and Impact
MAPSChatsCollaboration in Medical Affairs: Increasing Value and Impact
Matt Birnholz, MD
Renu Juneja, PhD
Matt Birnholz, MD
Justin O’Rourke, PhD, MBA
Rehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
MAPSChatsRehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
Matt Birnholz, MD
Dr. Susanna Gallani
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
Combatting Challenges & Health Disparities in Colorectal Cancer Care
Project Oncology®Combatting Challenges & Health Disparities in Colorectal Cancer Care
Jacob Sands, MD
Edith Mitchell, MD, MACP, FCPP, FRCP
CME
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
MinuteCE®Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Adam J. Luginbuhl, MD
Shifting Gears in Cardio-Renal-Metabolic Care: Harnessing Evidence-Based Therapies to Optimize Patient Outcomes
CME/CEShifting Gears in Cardio-Renal-Metabolic Care: Harnessing Evidence-Based Therapies to Optimize Patient Outcomes
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Stephen J. Greene, MD, FACC, FHFSA
Anne Louise Peters, MD
Understanding the Microbiome’s Role in IBD Management
MinuteCE®Understanding the Microbiome’s Role in IBD Management
Florence Odufalu, MD
Beyond Biology: Environmental and Lifestyle Influences in IBD
MinuteCE®Beyond Biology: Environmental and Lifestyle Influences in IBD
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Florence Odufalu, MD
Targeting Inflammation in IBD: Localized vs Systemic Strategies
MinuteCE®Targeting Inflammation in IBD: Localized vs Systemic Strategies
David T. Rubin, MD
Michael Dolinger, MD, MBA
Industry Feature
Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Medical Industry FeatureIdentifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Sandhya Panch, MD, MPH
Debunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Medical Industry FeatureDebunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Clay Jackson, MD
Amita Patel, MD, CMD
The Corticosteroid Journey in PMR: Understanding the Patient Experience
Medical Industry FeatureThe Corticosteroid Journey in PMR: Understanding the Patient Experience
Charles Turck, PharmD, BCPS, BCCCP
Rodney Daniel, MD
Grace C Wright, MD, PhD, FACR
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Sarah Sammons, MD
BRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Medical Industry FeatureBRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Sharyn N. Lewin, MD, FACS, FACOG
Dana Chase, MD
Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Project Oncology®Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Jennifer Caudle, DO, FACOFP
Ida Micaily, MD
Jeffrey Varanelli, OD